Back to VA Vanguard Capital Management LLC
TTRX
2 quarters
Position history for VAVanguard Capital Management LLC's holdings in Turn Therapeutics Inc.
Yes. Vanguard Capital Management holds 74,301 shares of TTRX (Turn Therapeutics), worth $542,397, as of its Q2 2026 13F filing. It increased the position by 24,851 shares (+50.3%) from Q1 2026. Vanguard Capital Management has held TTRX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$542,397
Current Shares
74,301
Total Value Change
+$384,157
Total Shares Change
+24,851
Quarter-by-Quarter History
Other major holders of TTRX: IEQ Capital, LLC, Millennium Management LLC, BlackRock, Inc., Jefferies Financial Group Inc.